Freshpet - FRPT Stock Forecast, Price & News

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Freshpet in the last twelve months. There are currently 4 hold ratings, 9 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" FRPT shares.
View FRPT analyst ratings or view top-rated stocks.

14 Wall Street analysts have issued 1 year price objectives for Freshpet's stock. Their FRPT share price forecasts range from $60.00 to $100.00. On average, they predict the company's share price to reach $77.64 in the next twelve months. This suggests a possible upside of 20.5% from the stock's current price.
View analysts price targets for FRPT or view top-rated stocks among Wall Street analysts.

Freshpet's stock was trading at $52.77 at the beginning of the year. Since then, FRPT stock has increased by 22.1% and is now trading at $64.43.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023.
View our FRPT earnings forecast.

Freshpet, Inc. (NASDAQ:FRPT) issued its earnings results on Monday, November, 8th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by $0.12. The company earned $107.59 million during the quarter, compared to analyst estimates of $114.31 million. Freshpet had a negative trailing twelve-month return on equity of 7.55% and a negative net margin of 12.07%. The firm's revenue for the quarter was up 27.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.09 EPS.

Freshpet updated its FY 2022 earnings guidance on Monday, January, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $575.00M-, compared to the consensus revenue estimate of $581.17 million.

27 employees have rated Freshpet Chief Executive Officer William Cyr on Glassdoor.com. William Cyr has an approval rating of 94% among the company's employees. This puts William Cyr in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 78.0% of employees surveyed would recommend working at Freshpet to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Freshpet investors own include Walt Disney (DIS), Block (SQ), DocuSign (DOCU), NVIDIA (NVDA), Netflix (NFLX), Advanced Micro Devices (AMD), Etsy (ETSY), Roku (ROKU), Shopify (SHOP) and PayPal (PYPL).

Freshpet trades on the NASDAQ under the ticker symbol "FRPT."

Freshpet's stock is owned by many different retail and institutional investors. Top institutional investors include Riverbridge Partners LLC (1.74%), Emerald Advisers LLC (1.11%), Emerald Mutual Fund Advisers Trust (0.84%), Redwood Investments LLC (0.52%), Fisher Asset Management LLC (0.46%) and New York State Common Retirement Fund (0.36%). Insiders that own company stock include Cathal Walsh, Charles A Norris, Daryl G Brewster, Ivan Garcia, Lawrence S Coben, Richard A Kassar, Robert C King, Scott James Morris, Stephen Macchiaverna, Stephen Weise, Walter N George and William B Cyr.
View institutional ownership trends.

Shares of FRPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of FRPT stock can currently be purchased for approximately $64.43.

Freshpet (NASDAQ:FRPT) has a market capitalization of $3.09 billion and generates $425.49 million in revenue each year. The company earns $-29,700,000.00 in net income (profit) each year or ($1.45) on an earnings per share basis.

The company employs 789 workers across the globe.

Freshpet's mailing address is 400 Plaza Drive 1st Floor, Secaucus NJ, 07094. The official website for the company is www.freshpet.com. The company can be reached via phone at (201) 520-4000 or via email at katie.turner@icrinc.com.